
Under the term of autoinflammatory diseases are gathered a number of inherited disorders secondary to mutations of genes coding for proteins that play a pivotal role in the regulation of the inflammatory response. Most of these disorders have generally an early onset, ranging from the first hours to the first decade of life. The clinical spectrum of these disorders is extremely variable (Table I).
1) Periodic Fevers 
          Familial Mediterranean Fever (FMF), Mevalonate-kinase  deficiency (MKD), and
          Tumour  necrosis factor (TNF) Receptor-Associated Periodic Syndrome  (TRAPS) are the three monogenic disorders  gathered under the term of
          Periodic  fevers.These diseases are characterized by  recurrent flares of systemic inflammation presenting as sudden fever episodes  associated
          with a dramatic elevation of acute phase reactants and with a number  of clinical manifestations, such as rash, serositis (peritonitis, pleuritis),
          lymphadenopathy, arthritis. Disease flares are usually separated by  symptom-free intervals of variable duration, characterized by a complete  well-being,
          normal growth and complete normalization of acute phase reactants. 
2) NLRPs-related Autoinflammatory diseases 
        In other disorders, systemic  inflammation is dominated by a characteristic urticarial rash associated with a  number of other clinical manifestations. 
            Familiar  Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells  Syndrome (MWS) and
            Chronic Infantile  Neurological Cutaneous and Articular Syndrome (CINCA) represent the  clinical spectrum associated to different mutations of a
            gene named NLRP3 (or CIAS1, or NALP3 cold induced autoinflammatory syndrome 1) coding for a  protein called Cryopyrin.
            These three disorders are also gathered under the  term of Cryopyrinopathies or cryopyrin-related  periodic syndromes (CAPS).
            Mutations of an other member of the NLRP family,  the NLRP12 gene, have been recently  associated with a new autoinflammatory disease. 
3) Granulomatous disorders
        Other diseases are characterized by  typical granulomatous formations. Blau’s  syndrome is characterized by noncaseating granulomatous inflammation
        affecting the joint, skin, and uveal tract   and is associated with mutations of the CARD15 (or NOD2) gene. 
4) Pyogenic disorders.
      A further group of diseases are dominated  by the presence of sterile pyogen abscesses affecting skin, joints and  bones  This include the
      Pyogenic Sterile Arthritis, Pyoderma  Gangrenosum and Acne (PAPA) syndrome secondary to  mutations of the CD2-binding protein 1
      (CD2BP1) gene and the Majeed syndrome, characterized by  chronic recurrent multifocal osteomyelitis, congenital dyserythropoietic  anemia,
      and neutrophilic dermatosis caused by mutations of the LPIN2 gene. Finally, a recently  identified autosomal recessive autoinflammatory syndrome, due to the
      Deficiency of the interleukin-1–receptor  antagonist (DIRA), is characterized by a neonatal onset multifocal
      osteomyelitis, periostitis, and skin pustulosis. 
| Table I | Diseases | Gene | Protein | Transmission | Clinical features | 
| Periodic/recurrent Fevers | Familial Mediterranean fever |  MEVF | Pyrin | AR | Short duration of fever episodes: 24-48 hours.  | 
| Mevalonate kinase deficency |  MVK | Mevalonate kinase | AR | Early onset (usually < 12 months). | |
| TNF receptor associated periodic syndrome | TNFRSF1A | p55 TNF receptor | AD | Prolonged fever episodes: 1-3 weeks    | |
| NLRPs-related diseases | FCAS, MWS, CINCA | CIAS1/NALP3/NLRP3 | Cryopyrin | AD | FCAS: rash, fever and arthralgia after cold exposure. | 
| NLRP12-associated Periodic Fever | NALP12/NLRP12 | NLRP12 | AD | Periodic fever after cold exposure, hearing loss | |
| Granulomatous disorders | Blau’s syndrome | CARD15/NOD2 16q12 | CARD15 | AD | Early onset (< 5 years) | 
| Pyogenic disorders | PAPA syndrome | PSTPIP1 | PSTPIP1 | AD | Pyogenic sterile arthritis, pyogenic gangrenosum, Cystic acne. Good response to IL-1 blockade. | 
| Majeed’s syndrome |  LPIN2  | LPIN2 | AR | Multifocal osteomyelitis, congenital dyserythropoietic anemia, inflammatory dermatosis | |
| DIRA | IL1RN | IL1 receptor antagonist | AR | Neonatal-onset multifocal osteomyelitis, periostitis, and pustulosis. Dramatic response to Anakinra. | 
FCAS: Familiar Cold Autoinflammatory Syndrome; MWS: Muckle-Wells Syndrome; CINCA: Chronic Infantile Neurological Cutaneous and Articular Syndrome; PAPA: Pyogenic Sterile Arthritis, Pyoderma Gangrenosum and Acne (PAPA) syndrome; CRMO: chronic recurrent multifocal osteomyelitis; DIRA (deficiency of the interleukin-1–receptor antagonist); AR: autosomal recessive; AD: autosomal dominant.